CREB-binding protein (CBP) is a transcriptional co-activator which is required by many transcription factors. Rubinstein±Taybi syndrome (RTS), which is an autosomal dominant syndrome characterized by abnormal pattern formation, is associated with mutations in the human CBP gene. Various abnormalities occur at high frequency in the skeletal system of heterozygous Cbp-de®cient mice, but some features of RTS such as cardiac anomalies do not, suggesting that some symptoms of RTS are caused by a dominant-negative mechanism. Here we report the characterization of homozygous Cbp-de®cient mice. Homozygous mutants died around E10.5±E12.5, apparently as a result of massive hemorrhage caused by defective blood vessel formation in the central nervous system, and exhibited apparent developmental retardation as well as delays in both primitive and de®nitive hematopoiesis. Cbp-de®cient embryos exhibited defective neural tube closure which was similar to those observed in twist-de®cient embryos. However, a decrease in the level of twist expression was not observed in Cbpde®cient embryos. Anomalous heart formation, a feature of RTS patients and mice mutated in the CBP-related molecule, p300, was not observed in Cbp-de®cient embryos. Since both Cbp and p300 are ubiquitously expressed in embryonic tissues including the developing heart, these results suggest that cardiac anomalies observed in RTS patients may be caused by a dominant negative effect of mutant CBP. q
Introduction
CREB-binding protein (CBP) was originally identi®ed as a co-activator of the transcription factor cAMP response element-binding protein (CREB). CBP acts as a bridging factor between CREB and the general transcription factor TFIIB (Chrivia et al., 1993; Kwok et al., 1994) . The CBP gene family contains at least one other member, p300, which was originally identi®ed as a protein which binds to the adenovirus E1A protein (Eckner et al., 1994) . Both CBP and p300 bind to the phosphorylated form of CREB and also to E1A (Arany et al., 1995; Lundblad et al., 1995) . CBP binds not only to phosphorylated CREB but also to the non-phosphorylated form of many other transcription factors including c-Jun (Arias et al., 1994) , c-Fos (Bannister and Kouzarides, 1995) , c-Myb (Dai et al., 1996; Oelgeschla È-ger et al., 1996) , nuclear hormone receptors (Chakravarti et al., 1996; Kamei et al., 1996) , Stat2 , and MyoD (for review, see Giles et al., 1998) . CBP contributes to the transcriptional activation mediated by each of these factors. CBP itself has histone acetyltransferase (HAT) activity (Bannister and Kouzarides, 1996; Ogryzko et al., 1996) and binds to other HAT proteins such as PCAF (Yang et al., 1996) and ACTR (Chen et al., 1997) , suggesting that it contributes to transcriptional activation by disrupting repressive chromatin structure via acetylation of histones. The recent ®nding that a subset of TAFs [TBP (TATA-binding protein)-associated factors] are integral components of PCAF and yeast SAGA/HAT complexes suggests a mechanistic connection between the RNA polymerase II machinery and CBP HAT activities (Grant et al., 1998; Ogryzko et al., 1998) .
CBP acetylates not only histones but also transcription factors. CBP directly acetylates p53 and GATA-1, and enhances their sequence-speci®c DNA binding activity (Gu and Roeder, 1997; Boyes et al., 1998) . Furthermore, CBP contributes to both trans-activation and trans-repression by acetylating certain transcription factors. Drosophila CBP acetylates TCF (T-cell factor), a high-mobility-group (HMG) domain protein, and this acetylation blocks the interaction between TCF and its coactivator b-catenin/ Armadillo (Waltzer and Bienz, 1998) . Acetylation of another HMG protein, HMG-I, also leads to transcriptional repression of the interferon-b gene promoter (Munshi et al., 1998) . In addition to HAT activity, CBP binds to multiple kinases, such as S6 kinase pp90RSK and cyclin-dependent kinases (Cdks) (Perkins et al., 1997) , and mediates the regulation of transcription by these kinases. CBP also binds to RNA helicase A, suggesting that this complex may induce local changes in chromatin structure (Nakajima et al., 1997) . Thus, CBP appears to control transcription through multiple mechanisms.
An important role for CBP in pattern formation was ®rst suggested by the ®nding that mutations in the human CBP gene at chromosome band 16p13.3 are associated with Rubinstein±Taybi syndrome (RTS) (Petrij et al., 1995) , an autosomal dominant dysmorphic syndrome (Rubinstein and Taybi, 1963; Hennekam et al., 1990 ). This syndrome is characterized by retarded growth and mental retardation (94 and 100%), broad thumbs and toes (100%), retarded osseous maturation (94%), microcephaly (84%) and typical craniofacial abnormalities including hypoplastic maxilla with narrow palate (100%), downward slanting palpebral ®ssures (100%) and an anterior fontanel (64%). In addition, RTS patients exhibit cardiac anomalies (33%), electroencephalogram abnormalities (60%), and ocular abnormalities at lower frequency. Generation of mutant mice is a useful method for elucidating the role of a given gene and to date, three groups have reported Cbp mutant mice. We demonstrated that disruption of one copy of the mouse Cbp gene by gene targeting caused skeletal abnormalities, such as large anterior fontanel, which partially resemble those of RTS patients (Tanaka et al., 1997) . Furthermore, the frequency of these abnormalities was affected by the genetic background. This indicates that at least some of the anomalies observed in RTS can be explained by haplo-insuf®ciency of CBP. However, some of the anomalies observed in RTS, such as cardiac anomalies, were not seen in the Cbp heterozygous mutant mice. Recently, Oike et al. (1999a) generated heterozygous Cbp mutant mice by an insertional mutation, and these mutant mice exhibited many of the anomalies, including cardiac anomalies, observed in RTS patients. A 121-kDa CBP fragment containing amino acids 1±1084 was expressed in the insertional mutant mice. Taken together, these results suggest that the characteristic features of RTS are caused by two mechanisms: haplo-insuf®ciency of CBP, and a dominantnegative effect of mutant CBP. The homozygous Cbp mutant mice generated by insertional mutation died at E9.5±E10.5 and showed defective neural tube closure, a lack of vascular network formation, and a defect in primitive hematopoiesis (Oike et al., 1999b) . However, it is unknown whether these defects are caused by loss of CBP or a dominant negative mechanism. Yao et al. (1998) generated Cbp-de®cient mice and p300-de®cient mice by gene targeting. Embryos lacking p300 died at E9.0±E11.5 and exhibited defects in neural tube closure. In addition, abnormal heart formation (an enlarged heart cavity) was observed in~20% of the p300-de®cient embryos at E10.5. Although the Cbp-de®cient mice in this study showed defective neural tube closure, no other characteristics were described.
The role of CBP in pattern formation has been analyzed using Drosophila Cbp mutants. CBP is a co-activator of the products of the segment polarity gene cubitus interruptus (ci) (Akimaru et al., 1997a) and Dorsal (Dl), a Drosophila homologue of NF-k B (Akimaru et al., 1997b) . Ci functions in the hedgehog (hh) pathway, and is a critical transcription factor for pattern formation (Domõ Âguez et al., 1996) . In response to Hh, Ci activates the decapentaplegic (dpp) and wingless (wg) genes, which encode the Drosophila homologues of TGF-b/BMP and Wnt family proteins, respectively. Dorsal activates twist gene expression, which is important for dorso-ventral polarity (Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1991) . This signaling pathway is conserved in vertebrates, and vertebrate CBP binds to GLI3 (Dai et al., 1999) , a vertebrate homolog of Ci, and to NF-k B (Perkins et al., 1997) , a vertebrate homolog of Dl. Consistent with these results, some anomalies in RTS resemble those observed in the two autosomal dominant diseases, Greig cephalopolysyndactyly syndrome and Saethre-Chotzen syndrome, which are caused by human GLI3 and TWIST gene mutations, respectively (Vortkamp et al., 1991; El Ghouzzi et al., 1997; Howard et al., 1997) . Furthermore, the level of Bmp7 expression was clearly reduced in Cbp heterozygous mutants (Tanaka et al., 1997) , suggesting that CBP contributes to the expression of dpp/Bmp in both Drosophila and mouse, and that a conserved signaling pathway is used for pattern formation in insects and mammals.
To further elucidate the role of CBP in development, we report here the characterization of homozygous Cbp-de®-cient mice. Homozygous mutants died around E10.5±E12.5 as a result of massive hemorrhage caused by a defect in blood vessel formation. In addition, they showed apparent developmental retardation, delayed hematopoiesis, defective neural tube closure, and defects in mesenchymal cells. Anomalous heart formation was not observed.
Results

Embryonic lethality of Cbp-null mutation
We have previously reported the generation of Cbp-de®-cient heterozygous mutant mice (Tanaka et al., 1997) . Homologous recombination was characterized by detection of a 13.0-kb SphI fragment with the 5 H Southern blot probe, a 6.0-kb BamHI fragment with the 3 H probe, and a 75-bp PCRfragment ampli®ed with the neo and Cbp reverse primers (Fig.  1a±c) . To obtain homozygous mutants, mice heterozygous for the Cbp mutation were intercrossed and the genotypes of the resulting offspring were determined at 4 weeks of age by Southern blot analysis of genomic DNA. Among 62 offspring derived from two independent lines, only and PCR data are shown in Fig. 1a,b . No statistically signi®-cant differences were observed in the number of Cbp 2/2 embryos obtained before day 10.5, when compared with the expected mendelian ratio (Table 1 ). The proportion of live Cbp 2/2 embryos decreased, with the time of death varying from 10.5 to 12.5 days postcoitus (dpc). The absence of Cbp mRNA was con®rmed in E11.5 Cbp 2/2 embryos by Northern blot analysis (Fig. 1c) . The CBP protein was completely lost in E11.5 Cbp 2/2 embryos, and the same level of the CBP-related protein, p300, was observed in Cbp 2/2 and wild-type embryos at E11.5 (Fig. 1d) . Thus most, if not all, homozygotes survived to 10.5 days of gestation but did not survive beyond 12.5 dpc.
Cranial neural tube closure defects Cbp
2/2 embryos exhibited cranial neural tube closure defects and exencephaly (Fig. 2a±d) . In wild-type mice, the neural tube initiates closure at E8.5 at multiple sites, including the forebrain-midbrain boundary and the anterior extremity of the forebrain (Geelen and Langman, 1977; Kaufman, 1979; Sakai, 1989) . Closure then spreads along the neural folds in both the rostral and caudal directions. By E9.5, closure is normally complete. In Cbp-null embryos, the cranial neural folds were elevated and approached each other medially but never initiated fusion. In E10.5 Cbp 2/2 embryos, the neural tube was irregular due to cellular invasion into the neural lumen, and variety of neural tube closure defects were observed. In some cases, eversion of the neural tissue from the telencepharon to the myelencepharon was observed, whereas in other cases the neural tube was open on the dorsal side with a lower degree of eversion of the neural tissue. Histological analysis revealed cellular disorganization in the spinal cord of E10.5 Cbp 2/2 embryos ( Fig.  2e ,f) and eversion of the neural tissue (Fig. 2g±j) . Some of the neuroepithelial cells had begun to degenerate. Furthermore, the density of neuroepithelial cells was lower in the mutants than in the wild-type at E11.5 (Fig. 2g,h ).
We also observed abnormalities in the mesenchymal region. In the forebrain region of wild-type embryos, the mesenchymal cells were well organized between the neuroepithelium and the surface ectoderm. In Cbp 2/2 embryos, the density of these cells was lower than in the Fig. 1 . Generation of Cbp null mice. (a) Genomic Southern blot analyses of wild-type (1/1), heterozygous (1/2), and homozygous (2/2) mutant mice. Genomic DNA was isolated from tail biopsies and digested with BglII for Southern blot analysis. The structure of the Cbp locus and targeting construct have been reported previously (Tanaka et al., 1997) . (b) PCR analyses of wild-type (1/1), heterozygous (1/2), and homozygous (-/-) mutant mice. (c) Northern blot analysis of Cbp mRNA. Total RNA was prepared from embryos of each genotype, resolved on formaldehyde-agarose gels, blotted onto a nitrocellulose membrane, and probed with the mouse Cbp cDNA fragment. (d) Immuno-detection of the CBP and p300 proteins. Extracts were prepared from embryonic ®broblasts derived from E10.5 fetuses and used for Western blotting with anti-CBP (upper), antip300 (middle), or anti-actin antibodies (lower). Protein loading was 30 (lanes 1 and 4), 60 (lanes 2 and 5), and 90 mg (lanes 3 and 6). wild-type, and intercellular contacts were reduced and the extracellular space was expanded (Fig. 3a±d) . Similar abnormalities were observed in the mesenchymal region of the trunk (Fig. 3e,f) .
The neural tube closure defects and the abnormalities in the mesenchymal region described above are very similar to the anomalies observed in twist-de®cient mice (Chen and Behringer, 1995) . Furthermore, Cbp is required for twist expression in Drosophila (Akimaru et al., 1997b) . We therefore examined twist expression in Cbp 2/2 embryos (Fig. 4) . Whole-mount in situ hybridization suggested that the level of twist expression was slightly lower in Cbp 2/2 embryos than that in wild-type embryos, although the spatial distribution of twist expression was similar in both. We then measured the twist mRNA level more quantitatively by using Northern blotting and RT-PCR methods. The results indicated that there was no difference in the twist mRNA level between the wild-type and Cbp-de®cient embryos. These results indicate that the neural tube closure defects in Cbp 2/2 embryos was not due to the loss of twist expression.
Hemorrhage causes embryonic lethality
Anatomical and histological examinations of Cbp 2/2 embryos revealed no gross abnormalities prior to E9.5 except for the apparent developmental retardation. In contrast, detailed microscopic analysis of the Cbp 2/2 embryos at E10.5 and E11.5 revealed extensive hemorrhage in the telencephalon and mesencephalon regions and segmental bleeding in areas corresponding to the VII/VIII cranial nerve complex, in addition to developmental retardation (Fig. 5a,b) . This hemorrhage was probably the principal cause of embryonic death. Although it was dif®cult to precisely assign the primary sites of hemorrhage by microscopic examination, the hemorrhage appeared to originate within the ganglia or the cranial nerves and to extend into telencephalon and mesencephalon regions. To examine whether the hemorrhages observed in the Cbp-de®cient embryos were due to defects in blood vessel morphogenesis or function, we performed whole-mount immunostaining with anti-PECAM-1 (platelet/endothelial cell adhesion molecule-1) antibody (Fig. 5c,d ). PECAM-1 (also called CD31), a member of the IgG superfamily, is expressed strongly at endothelial cell-cell junctions. The number of PECAM-1-positive cells in Cbp 2/2 embryos was lower than in the wild-type. Vascularity was also estimated by staining ventricle sections with an antibody directed against CD34, a cell surface glycoprotein selectively expressed in early blood vessels (Fig. 5e±h) . The number of CD34-positive cells was lower in mutant embryos than in wild-type embryos. In addition, the structure of the blood vessels in the everted neural tissue was strikingly abnormal. These results indicate that a defect in blood vessel formation leads to severe hemorrhage in Cbp 2/2 embryos.
Primitive and de®nitive hematopoiesis
Cbp 2/2 embryos were quite pale in color, whereas wildtype embryos appeared were red. This suggested the possibility of defective hematopoiesis in both the embryo body and the yolk sac (Fig. 6a,b) . To test for the presence of hematopoietic progenitor cells, hematopoietic colony-forming assays were performed using E9.5 and E10.5 yolk sacs by plating cells onto methylcellulose-containing media supplemented with appropriate cytokines. In addition, mixed erythroid-myeloid colonies were obtained by growing the cells in the presence of a combination of these growth factors. As shown in Fig. 6 , the total number of granulocyte-macrophage, erythroid, megakaryocyte and mixed colonies derived from precursors present in E9.5 Cbp 2/2 yolk sacs was 36±59% of the number derived from wild-type yolk sacs. The number of hematopoietic precursors recovered to 46±77% of the wild-type level when the progenitors were derived from E10.5 Cbp 2/2 yolk sacs. Thus, primitive hematopoiesis in the yolk sac was partly impaired. To examine de®nitive hematopoiesis in Cbp 2/2 embryos, similar hematopoietic colony-forming assays were performed using embryo bodies. The number of hematopoietic progenitor cells derived from precursors present in E9.5 Cbp 2/2 embryo bodies was 0±21% of the number derived from the wild-type embryos, but this number also increased (to 26±53% of that of wild-type) at E10.5. Thus, the defect in hematopoiesis in Cbp 2/2 embryos at E9.5±10.5 appeared to be partial, and is unlikely to explain the embryonic lethality of Cbp 2/2 embryos.
Ubiquitous expression of Cbp and p300
We observed multiple anomalies in Cbp 2/2 embryos including the hemorrhage due to impaired angiogenesis and neural tube defects described above. To examine whether these phenotypes were linked to the expression of Cbp in speci®c regions during development, we studied Cbp expression in E8.5±E10.5 wild-type embryos (Fig. 7) . Whole mount in situ hybridization and immunostaining indicated that Cbp is expressed in all regions of E8.5± E10.5 embryos.
The Cbp gene family contains at least one other member, p300 (Eckner et al., 1994) . To examine whether the abnormalities observed in Cbp 2/2 embryos were due to an exclusive expression of p300 in speci®c regions, we compared the expression patterns of Cbp and p300 in E10.5 wild-type embryos by immunohistochemistry (Fig. 8) . Both Cbp and p300 were expressed in all regions containing neural tube, heart, and somite, and there was no signi®cant difference between their expression patterns.
Discussion
In addition to this report, two other groups have reported the generation of homozygous Cbp mutant mice (Yao et al., 1998; Oike et al., 1999a,b) . Table 2 shows genotypic and phenotypic comparisons between the homozygous Cbp mutant mice reported to date. Comparison of phenotypes between these three mutants is useful in discriminating between phenotypes caused by a loss of CBP and those which result from the dominant negative action of the CBP fragment which was detected in the mutant generated by insertional mutagenesis. A defect in neural tube closure was seen in all three Cbp-de®cient mice, and both our mutants and the insertion-induced mutants showed developmental retardation and decreased vascularization, suggesting that these defects result from loss of CBP. The insertioninduced mutants exhibited more severe phenotypic defects than our mutants: the lethal point of the insertion-induced mutants was E9.5±E10.5, whereas our mutant mice died at E10.5±E11.5. The insertion-induced mutant embryos failed to survive beyond the stage of primitive hematopoiesis, and the total number of blood cells arising from the mutant yolk sac was reduced to 20% of wild-type. The erythroid and granulocyte-macrophage (GM) colony-forming capacities of E9.5 homozygous yolk sac cells were 22 and 69% of the respective colony-forming capacities of wild-type cells. In contrast, the total number of blood cells arising from the yolk sac in our mutant was about 50% of wildtype, and our mutant embryos survived beyond the stage of primitive hematopoiesis. Furthermore, de®nitive hematopoiesis was observed at E10.5 in our mutants, although the number of hematopoietic progenitor cells was 26±53% of wild-type. Thus, loss of CBP appeared to inhibit primitive and de®nitive hematopoiesis, whereas the dominant negative action of the CBP fragment appeared to inhibit primitive hematopoiesis and to completely block de®nitive hematopoiesis. This may explain why extensive hemorrhage was observed in our mutants, but not in the insertion-induced mutants. The lack of de®nitive hematopoiesis in the insertion-induced mutants may prevent observable hemorrhage. We observed neither defect in heart formation nor heart beat anomalies in our Cbp 2/2 mutants (data not shown). Cardiac anomalies were reported in 15% of the heterozygous mutants induced by insertional mutagenesis, but there was no description of homozygous mutants. These results suggest that cardiac anomalies were induced by the dominant negative action of the CBP fragment, but not by loss of CBP. The presence of cardiac defects may also explain why hemorrhage was not observed in the insertion-induced mutants.
The primary cause of death of Cbp 2/2 embryos appeared to be hemorrhage of the central nervous system. The hemorrhages observed in Cbp 2/2 embryos were similar to those seen in mice mutated in AML-1/CBFa (Okuda et al., 1996) or its interacting subunit CBFb /PEBP2 (Wang et al., 1996; Niki et al., 1997) . Furthermore, AML-1 is known to bind to, and interact functionally with CBP and p300 (Kitabayashi et al., 1998) . These observations raise the possibility that the hemorrhages observed in Cbp 2/2 embryos are due to decreased activity of the AML-1-CBFb complex. However, no similar hemorrhages were observed in trans-heterozygotes of Cbp and CBFb /PEBP2(data not shown), suggesting that decreased activity of transcription factor(s) other than AML1 may also contribute to hemorrhage in Cbp 2/2 embryos. The mechanism responsible for the observed defects in blood vessel formation is unknown at present. Oike et al. (1999b) reported that expression of angiogenic factors, such as VEGF and angiopoietins, and their receptors Flk-1, Flt-1, and Tie2, were unchanged in their Cbp mutant mice relative to wild-type mice. Since CBP binds to many transcription factors, it is possible that some other component(s) of VEGF signaling may be affected in the mutants. Alternatively, the abnormalities in the mesenchymal region in Cbp 2/2 embryos could be linked to a defect in blood vessel formation. The defects in mesenchymal cells could cause decreased expression of angiopoietin-1, which is critical for angiogenesis Suri et al., 1996) . It remains to be determined whether Cbp homozygous mutants exhibit altered expression of angiopoietin-1 during embryonic angiogenesis.
In Cbp 2/2 embryos in the present study, primitive and de®nitive hematopoiesis were decreased but not completely blocked. Comparison of the number of hematopoietic progenitor cells at E9.5 and E10.5 suggested a delay in hematopoiesis. This could occur as a result of either partial impairment of hematopoiesis or developmental retardation. A link between CBP and hematopoiesis was suggested by the utilization of CBP by multiple transcription factors, including c-Myb (Dai et al., 1996; Oelgeschla Èger et al., 1996) , GATA-1 (Blobel et al., 1998) , and AML-1 (Kitabayashi et al., 1998), all of which are required for hematopoiesis. In addition, CBP fusions with MLL or MOZ generated by chromosome translocation have been shown to be the transforming proteins of acute myeloid leukemia (Borrow et al., 1996; Sobulo et al., 1997) . The data obtained from the Cbp 2/2 embryos suggests that the CBP-related molecule p300 may be suf®cient for hematopoiesis in Cbp 2/2 embryos. The defective neural tube closure and the abnormalities in mesenchymal cells observed in Cbp 2/2 embryos have also been reported in twist-de®cient embryos (Chen and Behrin- ger, 1995). However, the level of twist expression in Cbp 2/2 embryos was almost the same as that in wild-type embryos. Although Cbp is required for the expression of twist in Drosophila (Akimaru et al., 1997b) , p300 may be suf®cient for the twist expression in mammals. It appears that altered activity of some other gene(s) rather than twist may be responsible to generate the observed phenotype. The activities of multiple transcription factors may be impaired by Cbp mutations, and one candidate effector of at least some of the consequence of Cbp mutation is the transcription factor HIF-1 (hypoxia-inducible factor 1), which binds to CBP and for which CBP is a co-activator Ebert and Bunn, 1998) . Hif1a-de®cient embryos have been shown to exhibit abnormalities, such as neural ,g ), anti-p300 antibody (b,e,h), or no primary antibody (c,f,i) was performed using sections including neural tube (a±c), heart (d±f), or somite (g±i). ac, common atrial chamber of heart; bc, bulbus cordis. (a±f, £100; g±i, £200).
tube defects and marked cell death within the cephalic mesenchyme, which partly resemble those of Cbp 2/2 embryos (Iyer et al., 1998) . CBP and p300 share a striking degree of sequence homology, and they act as co-activators for many transcriptional activators. Mice lacking p300 die at E9.0±E11.5 (Yao et al., 1998) and double heterozygotic mutation of Cbp and p300 is embryonic lethal, indicating that these two genes have similar functions and that the overall gene dosage of Cbp and p300 is important in embryonic development. Although defective neural tube closure was reported in p300-de®cient embryos, hemorrhage and abnormalities in hematopoiesis and in the mesenchymal region, which were apparent in Cbp-de®cient embryos, were not reported in p300-de®cient embryos (Yao et al., 1998) . Furthermore, abnormal heart formation (enlarged heart cavity) was reported in~20% of p300-de®cient embryos at E10.5. Since Cbp and p300 are expressed in similar patterns in heart, hematopoietic organs, and mesenchymal regions of E8.5±E10.5 embryos (Fig. 7) , the differences in the effects of their separate mutations may suggest subtle differences in the cellular roles of CBP and p300.
Experimental procedures
Generation of CBP-de®cient homozygous mutant mice
Cbp-de®cient heterozygous mutant mice were generated as described by Tanaka et al. (1997) . In the targeting vector, the 1.0-kb A¯II-EcoRI fragment containing the exon encoding amino acids 29-265 was replaced with a neomycin (neo) cassette driven by the phosphoglycerate kinase gene promoter. The ES cells used were TT2 cells derived from an F1 embryo resulting from a cross between C57BL/6 and CBA mice (Yagi et al., 1993) . The homologous nature of the recombination was con®rmed by Southern blot analysis. In addition, the PCR primers described in section 4.2 ampli®ed a 127-bp fragment from the wild-type allele, and a 75-bp fragment from the mutant allele. Chimeras were produced by injecting ES cells into 40 ICR 8-cell embryos, and then transplanting the embryos into the uteri of pseudopregnant females. Highly chimeric 6±8-week-old male progeny were bred with BALB/c or C57BL/6 females to produce heterozygous mice capable of transmitting the targeted allele through the germ line. Heterozygous mutant mice were bred to generate the homozygous mutants. The mice were maintained by the Division of Experimental Animal Research, RIKEN.
Genotyping, Northern blotting, and Western blotting
For Southern blot analysis, genomic DNA was isolated from cultured cells, embryos, or tail clippings by digestion overnight at 558C in lysis buffer (10 mM Tris±HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% SDS, 0.5 mg/ml proteinase K, 20 mg/ml RNase A) followed by phenol-chloroform extraction and ethanol precipitation. Genomic DNA (about 10 mg) was digested with SphI or BamHI and resolved on 0.8 or 0.5% agarose gels for Southern blotting. For PCR analysis, genomic DNA was isolated from yolk sacs by digestion for 60 min at 558C in lysis buffer (10 mM Tris± HCl, pH 8.4, 50 mM KCl, 2.5 mM MgCl 2 , 0.5% Tween 20, 0.5% NP-40, 0.5 mg/ml proteinase K), and then incubation at 948C for 10 min to inactivate proteinase K just prior to PCR analysis. PCR (40 cycles of 948C for 45 s, 558C for 25 s, and 728C for 3 min) was carried out using two of the following primers: forward Cbp Primer, 5
H -ACTTTACCA-CATTCTCCTCAACCCTCCAGG-3 H ; reverse Cbp primer, 5 H -TCAACAAGGGCAAGCTCAAGTCATGAATGG-3 H ; neo primer, 5
H -TCGTGCTTTACGGTATCGCCGCTCCC-GATT-3 H . Northern blotting was performed using RNA prepared from embryos and the mouse Cbp cDNA fragment as a probe. Western blotting of the CBP and p300 proteins was performed using lysates of embryonic ®broblasts, which were prepared from E10.5 embryos, as described previously (Tanaka et al., 1997) . The antibodies used were anti-CBP (C-1, Santa Cruz), anti-p300 (NM11, Pharmingen), and anti-actin antibodies (I-19, Santa Cruz).
Histological analysis and hematopoietic colonyforming assay
Embryos were ®xed in Bouin's ®xative or 4% paraformaldehyde (PFA), dehydrated and embedded in paraf®n. Sections (10 mm) were stained with hematoxylin and eosin according to standard procedures. For immunohistochemistry, embryos were ®xed in 4% PFA and washed three times with PBS, and then embedded in OCT compound. Cryostat sections were cut at 10 mm, dried in air and ®xed with 4% PFA for 15 min at room temperature. Blocking was performed with normal horse serum/PBS for anti-p300 and anti-CBP antibodies, or with normal rabbit serum/PBS for the anti-CD34 antibody. The anti-mouse CD34 (RAM34, PharMingen) rat monoclonal antibody, and anti-CBP (C-1, Santa Cruz) and anti-p300 (PharMingen) mouse monoclonal antibodies were used for immunohistochemistry at 5 mg/ ml at room temperature. The secondary antibodies were biotinylated rabbit anti-rat IgG or horse anti-mouse IgG (Vector Laboratories). Biotin was detected using a Vectastain kit according to the manufacturer's instructions, and peroxidase was detected by reaction with diaminobenzidine tetrahydrochloride (DAB).
Clonal culture of hematopoietic cells was performed in triplicate as described by Nakahata and Ogawa (1982) ; Yang et al. (1998) .
Whole-mount immunostaining
Whole-mount immunostaining was performed essentially as described by Winnier et al. (1997) . Embryos were dissected in PBS, ®xed overnight at 48C in Dent ®xative (4:1 methanol/DMSO), washed three times in 100% methanol, and then stored at 2208C until use. Embryos were bleached in 6% hydrogen peroxide in methanol for 1 h and then rehydrated in a reverse series of methanol dilutions and blocked in antibody dilution buffer (4% BSA, 10% goat serum in PBS) twice at 48C for 1 h to block nonspeci®c sites. The embryos were incubated at 48C overnight in anti-mouse PECAM-1 rat monoclonal antibody (MEC13.3, Caltag Laboratories) solution (2 mg/ml), followed by three quick washes with TBST (Tris±buffered saline with 0.1% Tween 20) containing 2 mM levamisole, then ®ve to seven 1-h washes at 48C. The embryos were then incubated in goat anti-rat alkaline phosphatase conjugate solution (Jackson ImmunoResearch Laboratories) in 10% goat serum, 4% BSA in PBS overnight at 48C. Embryos were washed with TBST, followed by washing in NTMT (100 mM NaCl, 100 mM Tris±HCl, pH 9.5, 50 mM MgCl 2 , 0.1% Tween 20). The color reaction was performed in coloring solution (4.5 ml/ml of NBT) in the dark without rocking. The reaction was stopped by washing three times in PBST (PBS with 0.1% Tween 20).
4.5. Whole-mount in situ hybridization and measurement of the twist mRNA level Whole-mount in situ hybridization using the 420-nucleotides (nucleotide number 1518-1938) digoxygenin-labeled twist RNA (Wolf et al., 1991) , or the 360-nucleotides digoxygenin-labeled Cbp RNA, which corresponds to the BamHIEcoRI region in the 5 H -untranslated region of the mouse Cbp gene, was performed essentially as described by Fu Èchtbauer (1995). Northern blotting was performed using total RNA prepared from E9.5 embryos and the mouse twist cDNA fragment as a probe. RT-PCR analysis was done using the mRNA selective PCR kit (Takara) as reported by Stoetzel et al. (1995) .
